Journalonko.de

Adrenal Tumors - Pathogenesis and Therapy

Rekrutierend

Studienbeginn:
September 2002

Letztes Update:
24.04.2024

Wirkstoff:
-

Indikation (Clinical Trials):
Pheochromocytoma, Adrenocortical Carcinoma, Adrenal Gland Neoplasms, Cushing Syndrome, Hyperaldosteronism, Syndrome

Geschlecht:
Alle

Altersgruppe:
Alle

Phase:
-

Sponsor:
University of Wuerzburg

Collaborator:
Deutsche Krebshilfe e.V., Bonn (Germany), German Federal Ministry of Education and Research,

Studienleiter

Martin Fassnacht, MD
Principal Investigator
U of Wuerzburg

Kontakt

Martin Fassnacht, MD
Kontakt:
Phone: 49-931-201-36507
E-Mail: fassnacht_m@medizin.uni-wuerzburg.de» Kontaktdaten anzeigen

Studienlocations
(1 von 1)

University of Wuerzburg
97080 Wuerzburg
(Bayern)
GermanyRekrutierend» Google-Maps
Ansprechpartner:
Martin Fassnacht, MD
E-Mail: fassnacht_m@medizin.uni-wuerzburg.de

Stefanie Hahner, MD
E-Mail: hahner_s@medizin.uni-wuerzburg.de» Ansprechpartner anzeigen

Studien-Informationen

Brief Summary:

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options

for malignant tumors are poor. The current study investigates different aspects of the

pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with

adrenocortical carcinoma.

Ein-/Ausschlusskriterien

Inclusion Criteria:

- adrenal tumor detected by imaging

Exclusion Criteria:

Studien-Arme

Tumor
Tumor material and corresponding biosamples from patients with adrenal tumors
control group
Biomaterial from patients without adrenal tumor

Quelle: ClinicalTrials.gov